Health Canada inspection
Cambrex Whippany Inc (Halo Pharmaceutical Inc D/B/A Cambrex Whippany Inc): Health Canada inspection of Dec 20, 2019
Health Canada · GMP · rating C
Key facts
| Establishment | Cambrex Whippany Inc (Halo Pharmaceutical Inc D/B/A Cambrex Whippany Inc) |
|---|---|
| City | Whippany |
| Province | NJ |
| Country | United States |
| Program | GMP |
| Start date | Dec 9, 2019 |
| End date | Dec 20, 2019 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.